or Try an Advanced Search...

    Technical Analysis for XOMAP - XOMA Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock

    Grade Last Price % Change Price Change
    A 25.33 1.31% 0.33
    XOMAP closed down 0.31 percent on Friday, June 7, 2024, on 35 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical XOMAP trend table...
    Date Alert Name Type % Chg
    Cup with Handle Other 1.31%
    Calm After Storm Range Contraction 1.31%
    Narrow Range Bar Range Contraction 1.31%
    Stochastic Reached Oversold Weakness 1.31%
    Strong but Oversold Other 1.31%
    Gapped Down Weakness 1.31%
    Oversold Stochastic Weakness 1.31%
    Cup with Handle Other 1.00%
    Calm After Storm Range Contraction 1.00%
    Narrow Range Bar Range Contraction 1.00%
    Older End-of-Day Signals for XOMAP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 2 hours ago
    Rose Above Previous Day's High about 2 hours ago
    Rose Above Upper Bollinger Band about 2 hours ago
    Rose Above 10 DMA about 2 hours ago
    2x Volume Pace about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    XOMAP Chart by TradingView
    Basic chart:

    Profile

    XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.
    Classification
    Keywords: Biotechnology

    Is XOMAP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss
    May 9 XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
    May 7 Certara, Inc. (CERT) Q1 Earnings Meet Estimates
    May 7 Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
    Apr 30 XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
    Apr 25 XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
    Apr 20 XOMA (NASDAQ:XOMA) shareholders have earned a 16% CAGR over the last five years
    Mar 19 XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
    Mar 8 XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023
    Mar 8 XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
    See more XOMAP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 25.3998
    52 Week Low 20.502
    Average Volume 1,258
    200-Day Moving Average 23.56
    50-Day Moving Average 24.99
    20-Day Moving Average 25.14
    10-Day Moving Average 25.14
    Average True Range 0.13
    RSI (14) 47.09
    ADX 29.95
    +DI 36.09
    -DI 33.02
    Chandelier Exit (Long, 3 ATRs) 24.92
    Chandelier Exit (Short, 3 ATRs) 25.27
    Upper Bollinger Bands 25.36
    Lower Bollinger Band 24.93
    Percent B (%b) 0.18
    BandWidth 1.74
    MACD Line 0.03
    MACD Signal Line 0.06
    MACD Histogram -0.0249
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.00
    Resistance 3 (R3) 25.00 25.00 25.00
    Resistance 2 (R2) 25.00 25.00 25.00 25.00
    Resistance 1 (R1) 25.00 25.00 25.00 25.00 25.00
    Pivot Point 25.00 25.00 25.00 25.00 25.00
    Support 1 (S1) 25.00 25.00 25.00 25.00 25.00
    Support 2 (S2) 25.00 25.00 25.00 25.00
    Support 3 (S3) 25.00 25.00 25.00
    Support 4 (S4) 25.00